Platinum Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-695,505
| Closed | -$53.6M | – | 151 |
|
|
2023
Q2 | $53.6M | Sell |
695,505
-41,764
| -6% | -$3.33M | 1.86% | 17 |
|
|
2023
Q1 | $61.2M | Sell |
737,269
-66,690
| -8% | -$5.52M | 2.12% | 12 |
|
|
2022
Q4 | $69M | Buy |
803,959
+7,122
| +0.9% | +$564K | 2.63% | 11 |
|
|
2022
Q3 | $49.2M | Sell |
796,837
-166,910
| -17% | -$10.5M | 2.05% | 13 |
|
|
2022
Q2 | $59.6M | Sell |
963,747
-125,822
| -12% | -$7.79M | 2.25% | 11 |
|
|
2022
Q1 | $64.8M | Sell |
1,089,569
-30,763
| -3% | -$1.97M | 1.99% | 13 |
|
|
2021
Q4 | $81.3M | Sell |
1,120,332
-338,398
| -23% | -$23.3M | 2.26% | 13 |
|
|
2021
Q3 | $102M | Sell |
1,458,730
-60,303
| -4% | -$4.24M | 2.87% | 8 |
|
|
2021
Q2 | $105M | Sell |
1,519,033
-150,311
| -9% | -$10M | 2.42% | 11 |
|
|
2021
Q1 | $108M | Buy |
1,669,344
+89,588
| +6% | +$5.78M | 2.41% | 13 |
|
|
2020
Q4 | $92M | Sell |
1,579,756
-48,002
| -3% | -$2.9M | 2.12% | 15 |
|
|
2020
Q3 | $103M | Sell |
1,627,758
-14,274
| -0.9% | -$990K | 2.55% | 15 |
|
|
2020
Q2 | $126M | Sell |
1,642,032
-162,880
| -9% | -$12.5M | 2.88% | 13 |
|
|
2020
Q1 | $135M | Sell |
1,804,912
-951,771
| -35% | -$65.8M | 3.41% | 12 |
|
|
2019
Q4 | $179M | Buy |
2,756,683
+735,216
| +36% | +$47.9M | 3.55% | 11 |
|
|
2019
Q3 | $128M | Buy |
2,021,467
+5,474
| +0.3% | +$358K | 2.87% | 14 |
|
|
2019
Q2 | $136M | Sell |
2,015,993
-3,037
| -0.2% | -$200K | 3.2% | 12 |
|
|
2019
Q1 | $131M | Hold |
2,019,030
| – | – | 3.09% | 13 |
|
|
2018
Q4 | $126M | Hold |
2,019,030
| – | – | 4.26% | 9 |
|
|
2018
Q3 | $156M | Sell |
2,019,030
-1,025,900
| -34% | -$77.5M | 4.42% | 10 |
|
|
2018
Q2 | $216M | Hold |
3,044,930
| – | – | 5.1% | 6 |
|
|
2018
Q1 | $230M | Hold |
3,044,930
| – | – | 6.4% | 5 |
|
|
2017
Q4 | $218M | Buy |
3,044,930
+145,300
| +5% | +$11M | 5.78% | 4 |
|
|
2017
Q3 | $235M | Buy |
2,899,630
+10,100
| +0.3% | +$772K | 5.94% | 5 |
|
|
2017
Q2 | $205M | Buy |
2,889,530
+419,700
| +17% | +$27.9M | 5.55% | 5 |
|
|
2017
Q1 | $168M | Buy |
2,469,830
+1,137,500
| +85% | +$80M | 4.65% | 10 |
|
|
2016
Q4 | $95.4M | Buy |
1,332,330
+117,800
| +10% | +$8.76M | 2.81% | 16 |
|
|
2016
Q3 | $96.1M | Buy |
1,214,530
+112,500
| +10% | +$9.14M | 2.24% | 19 |
|
|
2016
Q2 | $91.9M | Buy |
1,102,030
+218,100
| +25% | +$19.4M | 2.28% | 17 |
|
|
2016
Q1 | $81.2M | Buy |
883,930
+870,930
| +6,699% | +$78.5M | 1.8% | 21 |
|
|
2015
Q4 | $1.31M | Buy |
+13,000
| New | +$1.35M | 0.03% | 63 |
|
|
2014
Q1 | – | Sell |
-5,640
| Closed | -$423K | – | 94 |
|
|
2013
Q4 | $423K | Sell |
5,640
-93,570
| -94% | -$6.52M | 0.01% | 85 |
|
|
2013
Q3 | $6.24M | Sell |
99,210
-106,000
| -52% | -$6.34M | 0.11% | 51 |
|
|
2013
Q2 | $10.5M | Buy |
+205,210
| New | +$10.7M | 0.2% | 42 |
|
Other funds holding GILD
Platinum Investment Management's GILD Position: Q3 2023 in Review
Platinum Investment Management sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 695,505 shares — an estimated $53.6M sold.
Platinum Investment Management first reported a position in GILD in Q2 2013 and held it in 34 quarters. The position peaked at $235M in Q3 2017. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.
- Platinum Investment Management reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
- Platinum Investment Management sold 695,505 Gilead Sciences shares in Q3 2023, an estimated $53.6M.
- Platinum Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 34 quarters.
- Platinum Investment Management's Gilead Sciences position peaked at $235M in Q3 2017.
- 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.
Based on Platinum Investment Management's 13F filing for Q3 2023, filed 3 Nov 2023.